Options: Show MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chronic gastritis | x | x | ||||||||||||
Duodenal ulcer | x | x | x | x | x | x | x | x | x | x | x | x | ||
Gastric ulcer | x | x | x | x | x | x | ||||||||
Gastrooesophageal reflux disease | x | x | x | x | x | x | x | x | x | x | x | x | ||
Heartburn | x | x | x | x | x | x | x | x | x | x | ||||
Infection | x | x | x | x | x | x | x | |||||||
Non-erosive reflux disease | x | x | x | x | ||||||||||
Peptic ulcer | x | x | ||||||||||||
Regurgitation | x | x | x | x | ||||||||||
Ulcer | x | x | x | x | x | x | x | x | x | x | x | x | ||
Zollinger-Ellison syndrome | x | x | x | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |